Repurposing of a drug designed for pain relief can quickly and reversibly slow biochemical and metabolic activities in cells and organs and could facilitate organ transplantation and prevent tissue ...
Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies, today announced the completion of a 10-day study conducted by the Charles River International, Inc.
JOHANNESBURG: Cell C, South Africa's fourth-largest mobile ... Mendes said the group's free cash flow before debt obligations is expected to turn positive in about two months, while its ...